APA (7th ed.) Citation

JS, L., S, H., R, P., PM, C., TR, J. E., H, L., . . . J, S. (2025). A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma. Cell reports. Medicine, 6(6), 102165. https://doi.org/10.1016/j.xcrm.2025.102165

Chicago Style (17th ed.) Citation

JS, Lopez, et al. "A Phase 1/2a Dose-finding Study and Biomarker Assessment of Oral Lisavanbulin in Patients with High-grade Glioma or Glioblastoma." Cell Reports. Medicine 6, no. 6 (2025): 102165. https://doi.org/10.1016/j.xcrm.2025.102165.

MLA (9th ed.) Citation

JS, Lopez, et al. "A Phase 1/2a Dose-finding Study and Biomarker Assessment of Oral Lisavanbulin in Patients with High-grade Glioma or Glioblastoma." Cell Reports. Medicine, vol. 6, no. 6, 2025, p. 102165, https://doi.org/10.1016/j.xcrm.2025.102165.